Science
New post-infection treatment for COVID-19 identified
The research team modified GC376 using a tool called deuteration to test its efficacy against SARS-CoV-2
Large-scale drug analysis reveals potential new COVID-19 antivirals
While COVID-19 vaccines are being rolled out, there are still few drug options that can be used to treat patients with the virus
Delta variant is dangerous and is continuing to evolve and mutate: WHO chief
Delta variant is expected to rapidly outcompete other variants and become the dominant variant over the coming months
Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases
Will one dose of a two-dose COVID-19 vaccine protect me?
There’s a concern the shots eventually might lose their effectiveness if variants evolve enough
Johnson & Johnson's single-dose vaccine shows promising signs against Delta variant
According to the company report, the vaccine generated strong, persistent activity against the Delta variant
Novel face mask developed by MIT, Harvard can detect COVID-19 infection
The mask design has embedded tiny, disposable sensors that can be fitted into other face masks
Covaxin neutralises both Alpha, Delta variants of Covid-19: US top health institute
COVAXIN comprises a disabled form of SARS-CoV-2 that cannot replicate but still stimulates the immune system to make antibodies
Oxford study says mixing COVID-19 vaccines gives good protection
The University of Oxford is leading the Com-COV study, run by the National Immunisation Schedule Evaluation Consortium
Current Covid vaccines may be less effective against Beta variant: Study
Spike proteins enable the virus to attach to and enter our cells, and all current vaccines are directed against them